AR226894A1 - Procedimiento para obtener(4-trifluormetil anilida de acido 5-metil isoxazol-4-carboxilico - Google Patents
Procedimiento para obtener(4-trifluormetil anilida de acido 5-metil isoxazol-4-carboxilicoInfo
- Publication number
- AR226894A1 AR226894A1 AR285378A AR28537881A AR226894A1 AR 226894 A1 AR226894 A1 AR 226894A1 AR 285378 A AR285378 A AR 285378A AR 28537881 A AR28537881 A AR 28537881A AR 226894 A1 AR226894 A1 AR 226894A1
- Authority
- AR
- Argentina
- Prior art keywords
- trifluormethyl
- carboxylic
- procedure
- obtaining
- methyl isoxazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Lubricants (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782854439 DE2854439A1 (de) | 1978-12-16 | 1978-12-16 | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
AR226894A1 true AR226894A1 (es) | 1982-08-31 |
Family
ID=6057414
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR279310A AR222680A1 (es) | 1978-12-16 | 1979-12-14 | Procedimiento para la preparacion de (4-trifluor-metil)-anilida de acido 5-metilisoxazol-4-carboxilico |
AR285378A AR226894A1 (es) | 1978-12-16 | 1981-05-19 | Procedimiento para obtener(4-trifluormetil anilida de acido 5-metil isoxazol-4-carboxilico |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR279310A AR222680A1 (es) | 1978-12-16 | 1979-12-14 | Procedimiento para la preparacion de (4-trifluor-metil)-anilida de acido 5-metilisoxazol-4-carboxilico |
Country Status (25)
Country | Link |
---|---|
US (2) | US4284786A (es) |
EP (1) | EP0013376B1 (es) |
JP (1) | JPS5583767A (es) |
AR (2) | AR222680A1 (es) |
AT (1) | ATE1067T1 (es) |
AU (1) | AU529341B2 (es) |
BG (1) | BG60764B2 (es) |
CA (1) | CA1129867A (es) |
DE (2) | DE2854439A1 (es) |
DK (1) | DK149886C (es) |
EG (1) | EG13926A (es) |
ES (2) | ES486758A1 (es) |
FI (1) | FI64154C (es) |
GR (1) | GR72731B (es) |
HU (1) | HU178015B (es) |
IE (1) | IE49126B1 (es) |
IL (1) | IL58951A (es) |
LU (1) | LU90466I2 (es) |
MX (2) | MX6174E (es) |
NL (1) | NL990037I2 (es) |
NO (1) | NO148925C (es) |
NZ (1) | NZ192400A (es) |
PH (1) | PH16627A (es) |
PT (1) | PT70596A (es) |
ZA (1) | ZA796793B (es) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3247454A1 (de) * | 1982-12-22 | 1984-06-28 | Laboratorios Bago S.A., Buenos Aires | Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
FR2538806B1 (fr) * | 1982-12-30 | 1986-02-21 | Bago Sa Labor | Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
US5268382A (en) * | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
US4935434A (en) * | 1988-01-26 | 1990-06-19 | Bristol-Myers Company | Antiarthritic isoxazole-4-carboxamides |
US5258397A (en) * | 1988-11-30 | 1993-11-02 | Novapharme | 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions |
FR2662692B1 (fr) * | 1990-05-30 | 1995-04-28 | Novapharme | Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique. |
US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
DD297328A5 (de) * | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
US5108999A (en) * | 1990-02-02 | 1992-04-28 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
KR100188801B1 (ko) * | 1990-05-18 | 1999-06-01 | 엥겔하르트 라피체 | 이속사졸-4카복스아미드 및 하이드록시알킬리덴 시아노아세트아미드 및 이들 화합물을 함유하는 약제학적 조성물 |
DE4127737A1 (de) * | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
US6133301A (en) * | 1991-08-22 | 2000-10-17 | Aventis Pharma Deutschland Gmbh | Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
EP0607776B1 (de) * | 1993-01-08 | 1998-12-09 | Hoechst Aktiengesellschaft | Verwendung von Leflunomid zur Hemmung von Tumornekrosefaktor alpha |
DK0607775T3 (da) * | 1993-01-08 | 1999-08-16 | Hoechst Ag | Anvendelse af leflunomid til inhibering af interleukin 1 beta |
EP0607777B1 (de) * | 1993-01-08 | 1998-12-09 | Hoechst Aktiengesellschaft | Verwendung von Leflunomid zur Hemmung von Interleukin 8 |
ES2124799T3 (es) * | 1993-01-08 | 1999-02-16 | Hoechst Ag | Empleo de leflunomida para la inhibicion de interleuquina 1 alfa. |
TW314467B (es) * | 1993-03-31 | 1997-09-01 | Hoechst Ag | |
DE4323636A1 (de) * | 1993-07-15 | 1995-01-19 | Hoechst Ag | Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung |
LT3589B (en) | 1993-11-30 | 1995-12-27 | Hoechst Ag | Using of known combination for treatment of rejection reaction by transplantation of organs |
US6335356B1 (en) | 1994-01-07 | 2002-01-01 | Sugen, Inc. | Method of treating a patient by parenteral administration of a lipophilic compound |
US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
US5624946A (en) * | 1994-07-05 | 1997-04-29 | Williams; James | Use of leflunomide to control and reverse chronic allograft rejection |
AU695907B2 (en) * | 1994-10-17 | 1998-08-27 | Hoechst Pharmaceuticals & Chemicals K.K. | Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases |
US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
DE19539638A1 (de) * | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
DE19702988A1 (de) * | 1997-01-28 | 1998-07-30 | Hoechst Ag | Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika |
US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
DE59801792D1 (de) * | 1997-08-08 | 2001-11-22 | Aventis Pharma Gmbh | Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid |
US7691890B2 (en) | 1998-03-11 | 2010-04-06 | James W. Williams | Anti-viral uses of leflunomide products |
US20050255071A1 (en) * | 1998-12-10 | 2005-11-17 | Aventis Pharma Deutschland Gmbh | Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors |
DE19908527C2 (de) | 1999-02-26 | 2001-08-30 | Aventis Pharma Gmbh | Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid |
US6566395B1 (en) | 1999-05-25 | 2003-05-20 | Biomedicines, Inc. | Methods of treating proliferative disorders |
DE19960443C2 (de) * | 1999-12-15 | 2002-05-08 | Aventis Pharma Gmbh | Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen |
CA2397601A1 (en) * | 1999-12-16 | 2001-06-21 | Teva Pharmaceutical Industries, Ltd. | Novel processes for making- and a new crystalline form of- leflunomide |
IL151196A0 (en) | 2000-02-15 | 2003-04-10 | Teva Pharma | A method for synthesizing leflunomide |
EP1473035A1 (en) * | 2000-02-15 | 2004-11-03 | Teva Pharmaceutical Industries Ltd. | Leflunomide of high purity |
AU2001284891A1 (en) * | 2000-08-14 | 2002-02-25 | Teva Pharmaceutical Industries Ltd. | Micronized leflunomide |
GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
EP1935416A3 (en) | 2001-04-05 | 2008-10-22 | Aventis Pharma Inc | (Z) -2-cyano-3-hydroxybut-2-enoic acid (4'-trifluoromethylphenyl) amide for the treatment of multiple sclerosis |
WO2003042193A1 (en) * | 2001-11-09 | 2003-05-22 | Geneva Pharmaceuticals, Inc. | Process for preparing 5-methylisoxazole-4-carboxylic-(4'-trifluoromethyl)-anilide |
US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
US20060024376A1 (en) * | 2004-07-30 | 2006-02-02 | The University Of Chicago | Methods and compositions for reducing toxicity associated with leflunomide treatment |
CN101242831A (zh) * | 2005-08-31 | 2008-08-13 | 兴和株式会社 | 类风湿性关节炎的预防和/或治疗方法 |
EP2125895B1 (en) * | 2007-02-02 | 2015-04-08 | Vegenics Pty Ltd | Vegf receptor antagonists for treating organ transplant alloimmunity and arteriosclerosis |
CN101817797B (zh) * | 2009-02-26 | 2013-04-10 | 江苏亚邦爱普森药业有限公司 | 高纯度3-甲基-n-[4-(三氟甲基)苯基]-4-异噁唑甲酰胺的合成方法 |
US9205577B2 (en) * | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
US11202853B2 (en) * | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
JOP20190207A1 (ar) | 2017-03-14 | 2019-09-10 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على بونيسيمود |
US10889548B2 (en) | 2018-03-26 | 2021-01-12 | Clear Creek Bio, Inc. | Compositions and methods for inhibiting dihydroorotate dehydrogenase |
WO2021176070A1 (en) | 2020-03-06 | 2021-09-10 | Actelion Pharmaceuticals Ltd | Methods of slowing brain volume loss |
CA3221343A1 (en) | 2021-10-11 | 2023-04-20 | Allitia DIBERNARDO | Methods of treating multiple sclerosis |
CA3220702A1 (en) | 2022-02-11 | 2023-08-17 | Actelion Pharmaceuticals Ltd | Methods of slowing an increase in brain ventricular volume |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4087534A (en) * | 1974-05-22 | 1978-05-02 | David Ovadia | N-haloalkylmio urazole pesticides |
DE2524959C2 (de) * | 1975-06-05 | 1983-02-10 | Hoechst Ag, 6000 Frankfurt | 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel |
NL178596C (nl) * | 1975-06-05 | 1986-04-16 | Hoechst Ag | Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden. |
DE2654797A1 (de) * | 1976-12-03 | 1978-06-08 | Hoechst Ag | Verfahren zur herstellung von isoxazolderivaten |
-
1978
- 1978-12-16 DE DE19782854439 patent/DE2854439A1/de not_active Withdrawn
-
1979
- 1979-12-11 ES ES486758A patent/ES486758A1/es not_active Expired
- 1979-12-11 ES ES486750A patent/ES486750A1/es not_active Expired
- 1979-12-12 EG EG748/79A patent/EG13926A/xx active
- 1979-12-13 EP EP79105142A patent/EP0013376B1/de not_active Expired
- 1979-12-13 FI FI793899A patent/FI64154C/fi not_active IP Right Cessation
- 1979-12-13 US US06/103,551 patent/US4284786A/en not_active Expired - Lifetime
- 1979-12-13 MX MX798546U patent/MX6174E/es unknown
- 1979-12-13 AT AT79105142T patent/ATE1067T1/de active
- 1979-12-13 DE DE7979105142T patent/DE2962929D1/de not_active Expired
- 1979-12-14 AU AU53853/79A patent/AU529341B2/en not_active Expired
- 1979-12-14 HU HU79HO2201A patent/HU178015B/hu unknown
- 1979-12-14 PT PT70596A patent/PT70596A/pt active IP Right Revival
- 1979-12-14 IE IE2426/79A patent/IE49126B1/en active Protection Beyond IP Right Term
- 1979-12-14 IL IL58951A patent/IL58951A/xx unknown
- 1979-12-14 GR GR60761A patent/GR72731B/el unknown
- 1979-12-14 NO NO794094A patent/NO148925C/no unknown
- 1979-12-14 AR AR279310A patent/AR222680A1/es active
- 1979-12-14 ZA ZA00796793A patent/ZA796793B/xx unknown
- 1979-12-14 DK DK534279A patent/DK149886C/da active
- 1979-12-14 NZ NZ192400A patent/NZ192400A/xx unknown
- 1979-12-14 PH PH23418A patent/PH16627A/en unknown
- 1979-12-14 JP JP16170079A patent/JPS5583767A/ja active Granted
- 1979-12-14 CA CA342,109A patent/CA1129867A/en not_active Expired
-
1981
- 1981-03-03 US US06/239,986 patent/US4351841A/en not_active Expired - Lifetime
- 1981-05-19 AR AR285378A patent/AR226894A1/es active
-
1984
- 1984-03-12 MX MX8403A patent/MX8403A/es unknown
-
1994
- 1994-02-23 BG BG98534A patent/BG60764B2/bg unknown
-
1999
- 1999-10-27 LU LU90466C patent/LU90466I2/fr unknown
- 1999-10-29 NL NL990037C patent/NL990037I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR226894A1 (es) | Procedimiento para obtener(4-trifluormetil anilida de acido 5-metil isoxazol-4-carboxilico | |
ES487400A0 (es) | Procedimiento para la fabricacion de acido metacrilico | |
MX4567E (es) | Procedimiento para preparar acido de-n-propilacetico | |
AR226854A1 (es) | Procedimiento para preparar derivados de acido trans-3-(4-oxo-4h-quinazolin-3-il)-2-propenoico | |
ES492989A0 (es) | Procedimiento para la obtencion de compuestos de acido ami- notiazolacetamido-3-cefem-4-carboxilico | |
MX5795E (es) | Procedimiento mejorado para la obtencion de metacroleina y acido metacrilico | |
AR222304A1 (es) | Procedimiento para preparar acido 4-isohexil-1-metilciclohexano-carboxilico | |
RO81071A (ro) | Procedeu pentru obtinerea acidului cianhidric | |
AR229152A1 (es) | Procedimiento para obtener derivados de acidos de 1-tioalcanoilprolina | |
MX5623E (es) | Procedimiento para preparar amidas de acido 1,2,3-triazolocarboxilico | |
MX4914E (es) | Procedimiento mejorado para la produccion de acido metacrilico | |
AR227884A1 (es) | Procedimiento para la obtencion de acido(fenil-2-benzotiazolil-6)-2-propionico | |
MX5760E (es) | Procedimiento de preparacion de derivados de acido 1-naftil-acetico | |
ES483447A0 (es) | Procedimiento para la obtencion de acidos azulmicos quimica-mente estabilizados | |
MX5224E (es) | Procedimiento para preparar anilidas de acido ciclopropanocarboxilico | |
IT8050073A0 (it) | (-)-b-idrossi-isobutirrico procedimento per produrre acido d | |
MX5329E (es) | Procedimiento para la preparacion de alcoxialquil amidas de acido 4-(p-trifluorometilfenoxi)-alfa-fenoxipropionico | |
MX5206E (es) | Procedimiento para la preparacion de fenoxi-alfa-vinil-bencil-esteres de acido ciclopropancarboxilico | |
ES492693A0 (es) | Procedimiento para preparar derivados de acido acilaminoben-zoico | |
MX150295A (es) | Procedimiento mejorado para obtener acido cianurico | |
ES497506A0 (es) | Procedimiento para la obtencion de hidrazida de acido al- quildifenileter-sulfonico | |
ES497535A0 (es) | Procedimiento de producir acido 2-hidroxinaftalen-3-carboxi-lico | |
MX5372E (es) | Procedimiento para la preparacion de cianometilester de acido 4-(p-trifluorometil fenoxi)-alfa-fenoxipropionico | |
ES489318A0 (es) | Procedimiento para la obtencion de compuestos de acido 17-c-esteroide- -propionico | |
MX155608A (es) | Procedimiento mejorado para la obtencion de cloruro de acido gamma-cloro-acetoacetico |